Publications
Download CSV
Download XLSX
Download TXT
Tables
2024 (853)
2023 (887)
2022 (831)
2021 (892)
2020 (640)
2019 (727)
2018 (651)
2017 (681)
2016 (664)
2015 (429)
2014 (376)
2013 (319)
2012 (245)
2011 (163)
2010 (139)
2000 (2)
1977 (2)
All (8501)
Infrastructure Units
Infrastructure Units list
Infrastructure Units table
Researchers
Subset
Documentation
About
Contact
Software
Login
Cancer Immunol. Immunother.
JSON
ISSN
1432-0851
ISSN-L
0340-7004
IUID
ed5a89c6a7324b95b983d6aa76e58a8b
Modified
2020-11-27T13:14:02.514Z
Created
2017-10-20T15:09:03.134Z
Year 2023
PubMed
DOI
Crossref
A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer.
Thomsen LCV
,
Honoré A
,
Reisæter LAR
, ...,
Kalland KH
,
Beisland C
Cancer Immunol. Immunother.
72
(7) 2357-2373 [2023-07-00; online 2023-03-20]
Clinical Genomics Uppsala [Service]
Year 2022
PubMed
DOI
Crossref
Parvimonas micra is associated with tumour immune profiles in molecular subtypes of colorectal cancer.
Löwenmark T, Li X, Löfgren-Burström A, ..., Edin S,
Palmqvist R
Cancer Immunol. Immunother.
71
(10) 2565-2575 [2022-10-00; online 2022-03-17]
Affinity Proteomics Uppsala [Service]
Clinical Genomics Umeå [Service]
Year 2014
PubMed
DOI
Crossref
Immunomodulatory activity of commonly used drugs on Fc-receptor-mediated human natural killer cell activation.
Theorell J,
Gustavsson AL
, Tesi B, ..., Lundbäck T, Bryceson YT
Cancer Immunol. Immunother.
63
(6) 627-641 [2014-06-00; online 2014-03-30]
Chemical Biology Consortium Sweden (CBCS) [Collaborative]
SciLifeLab Data Centre
Publications
9.5.1